Antiretroviral therapy non-adherence among children living with HIV in Dire Dawa, Eastern Ethiopia : a case-control study
(2022) In BMC Pediatrics 22(1).- Abstract
Background: In 2018, nearly 90% of the global
children living with human immunodeficiency virus (HIV) were in
sub-Saharan Africa (SSA). Compared to the adult population,
antiretroviral therapy (ART) coverage among children was limited.
However, adherence remained a problem among children though they had
limited access to ART. This study was conducted to identify the risk
factors of non-adherence to ART among children aged 6 to 17 years.
Methods:: This case-control study was conducted in 2020 using data
obtained from clinical record reviews and self-reported data from 272
caregivers of HIV-infected children aged 6–17 years. Cases and controls
represented children with poor versus children... (More)Background: In 2018, nearly 90% of the global
(Less)
children living with human immunodeficiency virus (HIV) were in
sub-Saharan Africa (SSA). Compared to the adult population,
antiretroviral therapy (ART) coverage among children was limited.
However, adherence remained a problem among children though they had
limited access to ART. This study was conducted to identify the risk
factors of non-adherence to ART among children aged 6 to 17 years.
Methods:: This case-control study was conducted in 2020 using data
obtained from clinical record reviews and self-reported data from 272
caregivers of HIV-infected children aged 6–17 years. Cases and controls
represented children with poor versus children with good adherence to
ART, respectively. Good adherence was defined based on a past 30-day
physician adherence evaluation of taking ≥ 95% of the prescribed doses.
Binary logistic regression was used to identify factors associated with
non-adherence to ART. All statistical tests are defined as statistically
significant at P-values < 0.05. Results:: Of the 272 children, for
whom data were obtained, 78 were cases and 194 were controls; females
accounted for 56.3%, 32% attended secondary school, and for 83.1%, the
reporting caregivers were biological parents. Non-adherent children had
higher odds of association with the following risk factors: a caregiver
who is a current substance user (aOR = 2.87, 95% CI: 1.44, 5.71), using
AZT-and ABC-based regimen compared to the TDF-regimen (AZT-based, aOR =
4.12, 95% CI: 1.43, 11.86; ABC-based, aOR = 5.58, 95% CI: 1.70, 18.30),
and had an increase in viral load from baseline compared to those
remained undetectable (remained at or decreased to < 1000, aOR =
4.87, 95% CI: 1.65, 14.33; remained at ≥ 1000, aOR = 9.30, 95% CI: 3.69,
23.46). In contrast, non-adherent children had 66% lower odds of being
at early adolescent age compared to 6–9 years old (10–14 years, aOR =
0.34, 95% CI: 0.12, 0.99) and had 70% lower odds of being aware of their
HIV status (aOR = 0.30, 95% CI: 0.13, 0.73). Conclusion:: Technical
support to caregivers to build disclosure self-efficacy, identifying the
appropriate regimen for children, counseling on viral load suppression
on subsequent visits, and helping caregivers avoid or reduce substance
use may help improve the problem of children’s non-adherence to ART.
- author
- Mengesha, Melkamu Merid
LU
; Embibel, Mulugeta ; Gobena, Tesfaye ; Tunje, Abayneh LU ; Jerene, Degu LU and Hallström, Inger Kristensson LU
- organization
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- and viral load, Children, HIV status disclosure, Non-adherence to ART
- in
- BMC Pediatrics
- volume
- 22
- issue
- 1
- article number
- 653
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:36357856
- scopus:85141610922
- ISSN
- 1471-2431
- DOI
- 10.1186/s12887-022-03697-1
- project
- eHealth as an aid for facilitating and supporting self-management in families with long-term childhood illness – development, evaluation and implementation in clinical practice
- Improving adherence to antiretroviral therapy among adolescents living with HIV in Ethiopia
- language
- English
- LU publication?
- yes
- id
- 759ba76e-2678-425c-b8dd-d723eba05596
- date added to LUP
- 2022-12-05 12:07:13
- date last changed
- 2025-03-22 01:25:03
@article{759ba76e-2678-425c-b8dd-d723eba05596, abstract = {{<p>Background: In 2018, nearly 90% of the global <br> children living with human immunodeficiency virus (HIV) were in <br> sub-Saharan Africa (SSA). Compared to the adult population, <br> antiretroviral therapy (ART) coverage among children was limited. <br> However, adherence remained a problem among children though they had <br> limited access to ART. This study was conducted to identify the risk <br> factors of non-adherence to ART among children aged 6 to 17 years. <br> Methods:: This case-control study was conducted in 2020 using data <br> obtained from clinical record reviews and self-reported data from 272 <br> caregivers of HIV-infected children aged 6–17 years. Cases and controls <br> represented children with poor versus children with good adherence to <br> ART, respectively. Good adherence was defined based on a past 30-day <br> physician adherence evaluation of taking ≥ 95% of the prescribed doses. <br> Binary logistic regression was used to identify factors associated with <br> non-adherence to ART. All statistical tests are defined as statistically<br> significant at P-values < 0.05. Results:: Of the 272 children, for <br> whom data were obtained, 78 were cases and 194 were controls; females <br> accounted for 56.3%, 32% attended secondary school, and for 83.1%, the <br> reporting caregivers were biological parents. Non-adherent children had <br> higher odds of association with the following risk factors: a caregiver <br> who is a current substance user (aOR = 2.87, 95% CI: 1.44, 5.71), using <br> AZT-and ABC-based regimen compared to the TDF-regimen (AZT-based, aOR = <br> 4.12, 95% CI: 1.43, 11.86; ABC-based, aOR = 5.58, 95% CI: 1.70, 18.30), <br> and had an increase in viral load from baseline compared to those <br> remained undetectable (remained at or decreased to < 1000, aOR = <br> 4.87, 95% CI: 1.65, 14.33; remained at ≥ 1000, aOR = 9.30, 95% CI: 3.69,<br> 23.46). In contrast, non-adherent children had 66% lower odds of being <br> at early adolescent age compared to 6–9 years old (10–14 years, aOR = <br> 0.34, 95% CI: 0.12, 0.99) and had 70% lower odds of being aware of their<br> HIV status (aOR = 0.30, 95% CI: 0.13, 0.73). Conclusion:: Technical <br> support to caregivers to build disclosure self-efficacy, identifying the<br> appropriate regimen for children, counseling on viral load suppression <br> on subsequent visits, and helping caregivers avoid or reduce substance <br> use may help improve the problem of children’s non-adherence to ART.</p>}}, author = {{Mengesha, Melkamu Merid and Embibel, Mulugeta and Gobena, Tesfaye and Tunje, Abayneh and Jerene, Degu and Hallström, Inger Kristensson}}, issn = {{1471-2431}}, keywords = {{and viral load; Children; HIV status disclosure; Non-adherence to ART}}, language = {{eng}}, number = {{1}}, publisher = {{BioMed Central (BMC)}}, series = {{BMC Pediatrics}}, title = {{Antiretroviral therapy non-adherence among children living with HIV in Dire Dawa, Eastern Ethiopia : a case-control study}}, url = {{http://dx.doi.org/10.1186/s12887-022-03697-1}}, doi = {{10.1186/s12887-022-03697-1}}, volume = {{22}}, year = {{2022}}, }